Back to search
Trichotillomania
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Trichotillomania trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Trichotillomania trials you may qualify forThis trial aims to evaluate the efficacy, safety and tolerability of valbenazine, titrated to the subject's optimal dose of 40mg or 80mg, administered once dail…
This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will…
The impaired ability to suppress an inappropriate but pre-potent response (response inhibition; RI) characterizes several debilitating clinical problems, includ…
This study aims at evaluating the effectiveness of group-based cognitive behavioral therapy for trichotillomania at three clinical sites in Norway.
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.
To examine the effectiveness and clinical care outcomes of cognitive-behavioral therapy interventions at Massachusetts General Hospital (MGH).